530 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
451 | 12625845 | Pharmacology of phosphodiesterase 5 inhibitors. | 2003 Feb | 1 |
452 | 12625847 | Cardiovascular safety of PDE5 inhibitors. | 2003 Feb | 2 |
453 | 12694895 | Effect of sildenafil (Viagra) on cerebral blood flow velocity: a pilot study. | 2003 Apr 1 | 4 |
454 | 12695418 | PDE5 inhibitor sildenafil citrate augments endothelium-dependent vasodilation in smokers. | 2003 May | 4 |
455 | 12761347 | [3H]sildenafil binding to phosphodiesterase-5 is specific, kinetically heterogeneous, and stimulated by cGMP. | 2003 Jun | 13 |
456 | 12825143 | [Sex, erectile dysfunction, and the heart: a growing problem]. | 2003 Jun | 2 |
457 | 12825147 | [New treatment options for erectile dysfunction. Pharmacologic and nonpharmacologic options]. | 2003 Jun | 2 |
458 | 12841917 | Sildenafil in erectile dysfunction: a critical review. | 2003 | 2 |
459 | 12842049 | Three-dimensional structures of PDE4D in complex with roliprams and implication on inhibitor selectivity. | 2003 Jul | 1 |
460 | 12853767 | Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism. | 2003 Aug | 3 |
461 | 12934045 | Hypogonadism and erectile dysfunction: the role for testosterone therapy. | 2003 Aug | 2 |
462 | 12955149 | Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules. | 2003 Sep 4 | 1 |
463 | 14551572 | Phosphodiesterase type 5 inhibitors: a biochemical and clinical correlation survey. | 2003 Oct | 1 |
464 | 14562136 | Effect of PDE5 inhibition combined with free oxygen radical scavenger therapy on erectile function in a diabetic animal model. | 2003 Oct | 1 |
465 | 14562139 | Single step isolation of sildenafil from commercially available Viagra tablets. | 2003 Oct | 1 |
466 | 14569380 | [Drug therapy of erectile dysfunction--the current status]. | 2003 Oct | 2 |
467 | 14609619 | Overview of phosphodiesterase 5 inhibition in erectile dysfunction. | 2003 Nov 6 | 1 |
468 | 14609621 | Sildenafil in patients with cardiovascular disease. | 2003 Nov 6 | 1 |
469 | 14618646 | Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn: a review. | 2003 Dec | 2 |
470 | 14622499 | Molecular mechanisms and pharmacokinetics of phosphodiesterase-5 antagonists. | 2003 Dec | 1 |
471 | 14622500 | Erectile dysfunction in the cardiac patient. | 2003 Dec | 2 |
472 | 14652001 | Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. | 2003 Dec 26 | 1 |
473 | 14687446 | Sildenafil citrate does not affect cardiac contractility in human or dog heart. | 2003 | 2 |
474 | 14693300 | Switching patients with erectile dysfunction from sildenafil citrate to tadalafil: results of a European multicenter, open-label study of patient preference. | 2003 Nov | 2 |
475 | 11815339 | Sildenafil induces retinal vasodilatation in healthy subjects. | 2002 Feb | 4 |
476 | 11896473 | Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters. | 2002 Feb | 1 |
477 | 12002434 | Efficacy of vardenafil and sildenafil in facilitating penile erection in an animal model. | 2002 May-Jun | 2 |
478 | 12086542 | Neurologic, psychological, and aggressive disturbances with sildenafil. | 2002 Jul-Aug | 1 |
479 | 12145231 | Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes. | 2002 Aug | 4 |
480 | 12161769 | Tolerability and safety profile of sildenafil citrate (Viagra) in Latin American patient populations. | 2002 Aug | 1 |
481 | 12192104 | Effect of sildenafil on renin secretion in human subjects. | 2002 Sep | 1 |
482 | 12207947 | Viagra (sildenafil citrate) and ophthalmology. | 2002 Sep | 3 |
483 | 12209148 | Phosphodiesterase 5 inhibitors: current status and potential applications. | 2002 Sep | 2 |
484 | 12358156 | Erectile dysfunction: oral pharmacotherapy options. | 2002 Sep | 1 |
485 | 12414329 | Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction. | 2002 Sep | 4 |
486 | 12435622 | Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil--review of the literature. | 2002 Oct 29 | 2 |
487 | 12437503 | A Rho-kinase inhibitor, soluble guanylate cyclase activator and nitric oxide-releasing PDE5 inhibitor: novel approaches to erectile dysfunction. | 2002 Nov | 2 |
488 | 12442206 | [Sildenafil for treatment of severe pulmonary hypertension and commencing right-heart failure]. | 2002 Nov | 2 |
489 | 12494279 | Phosphodiesterase type 5 inhibitors for the treatment of erectile dysfunction in patients with diabetes mellitus. | 2002 Dec | 2 |
490 | 12572636 | Therapeutic strategies for managing erectile dysfunction: a step-care approach. | 2002 Dec | 2 |
491 | 12836729 | PDE-5 inhibition and sexual response: pharmacological mechanisms and clinical outcomes. | 2002 | 2 |
492 | 15570464 | Use of cGMP PDE5 inhibitors in the treatment of neuropathy: a review of the patent literature. | 2002 May | 1 |
493 | 11162575 | Identification and regulation of human PDE5A gene promoter. | 2001 Jan 26 | 4 |
494 | 11162576 | Regulation of human PDE5A2 intronic promoter by cAMP and cGMP: identification of a critical Sp1-binding site. | 2001 Jan 26 | 4 |
495 | 11289565 | Phosphodiesterase isoenzymes as pharmacological targets in the treatment of male erectile dysfunction. | 2001 Feb | 1 |
496 | 11289569 | Sildenafil citrate, a selective phosphodiesterase type 5 inhibitor: urologic and cardiovascular implications. | 2001 Feb | 1 |
497 | 11306686 | Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A. | 2001 May | 1 |
498 | 11351772 | Phosphodiesterase 5 inhibition: effects on the coronary vasculature. | 2001 Apr | 1 |
499 | 11408180 | Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues. | 2001 Jun | 1 |
500 | 11557915 | The effect of sildenafil on nitric oxide-mediated vasodilation in healthy men. | 2001 Sep | 2 |